Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Phase IIa crossover study of SLx-2101 in patients with hypertension
2007-000320-40Phase 2Completed
- Sponsor
- Surface Logix, Inc.
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing SLx-2101 active treatment arm with Placebo arm (2 arms). Primary endpoints: Office seated peripheral systolic blood pressure and Office seated peripheral diastolic blood pressure. Started Jan 2007; status: completed.
02
Drugs
slx-2101
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2007-000320-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000320-40.